Investment analysts say Oxitec’s GM mosquito technology “won’t work, is way too expensive, and is many years from generating even minuscule revenue”. Now three law firms have announced they are investigating. Claire Robinson reports
Source
Investment analysts say Oxitec’s GM mosquito technology “won’t work, is way too expensive, and is many years from generating even minuscule revenue”. Now three law firms have announced they are investigating. Claire Robinson reports